PharmExec Blog
Follow Us
RSS
Bookstore
Author Archives: Walter Armstrong
Pharma Gets the ProPublica Treatment
Alternative news organization and media allies investigate the industry’s payments to doctors—launching a fresh assault on the ethical status quo.
By Walter Armstrong
Last week, Big Pharma’s practice of paying doctors to do medical education, promote its products, or both was the focus of a multimedia blitz launched by ProPublica in collaboration with National Public Radio, the [...]
Posted in FDA, Legal, Medical Education, Meetings Tagged compliance, doctor payments, ethics, Medical Education, Pharma, transparency 6 Comments
Avandia, Pharma, and the New FDA
The Harvard prof who wrote the book on FDA (literally) deconstructs the decision on Avandia—and its future implications.
GlaxoSmithKline’s diabetes drug Avandia became mired in such controversy regarding its safety in recent years that it was dubbed “another Vioxx”—exactly what the pharmaceutical industry had vowed never to produce. Two weeks ago, FDA’s decided to restrict access [...]
Posted in FDA, Regulatory, Safety Tagged Avandia, FDA, GlaxoSmithKline, GSK, Regulatory, REMS 2 Comments
MedImmune Bets Its Fate on “Biobetters”
AstraZeneca’s biologics shop makes a decisive move in the biosimilars market.
MedImmune, the biologics shop bought by AstraZeneca (AZ) for a staggering $15 billion in 2007 promising one new drug a year for the foundering British firm, has made precious little news since the deal. But all of a sudden the post-Labor Day wires were crackling [...]
Posted in Biotech, Deals, Global, R&D, Strategy Tagged AstraZeneca, biobetters, biosimilars, Deals, MedImmune, R&D, Strategy 1 Comment
Why Won’t Andrew Witty Take the Dive? (Updated 7/30/10)
AIDS: An epidemic without end. It’s mostly fallen off the front pages—who has time or money or compassion for a decades-old global health crisis when we’ve got our own global economic crisis?—except for every two years when the International AIDS Conference comes around. The one held in Vienna last week earned some ink, but the [...]
Posted in Strategy 2 Comments
Justice to Pharma: "Do the Perp Walk!"